Monteris receives FDA clearance for Fusion-S planning software
Monteris Medical received FDA clearance for NeuroBlate Fusion-S software and released the upgrade for its robotic laser interstitial thermal therapy system.
Evidence notes
- Fusion-S adds 3D visualization and planning features for NeuroBlate procedures.
- Monteris stated that more than 200 cases had already used the software before clearance.
- The primary milestone was FDA clearance for Fusion-S planning software.
Company context
Develops minimally invasive neurosurgery systems centered on the NeuroBlate platform for MRI-guided laser interstitial thermal therapy in the brain. The company combines robotic control, cooled laser probe technology, software, and treatment-planning workflow to support targeted ablation of brain lesions in adult and pediatric patients.